Circadian Technologies Limited (ASX:CIR, OTCQX:CKDXY) is pleased to announce that it has appointed Dr Ian Leitch to the newly created position of Director – Clinical Research effective from 12 September 2011.
Dr Leitch will initially be based in the USA and will relocate to Australia in early 2012.
Dr Leitch has over fifteen years of research and management experience from drug discovery through clinical development in early stage and large biotechnology / pharmaceutical companies. For the past 5 years he has been within the Medical Sciences group at Amgen Inc in Thousand Oaks California involved in the development of novel therapeutics in Amgen’s oncology pipeline. In his role as Senior Manager in the Early Development Oncology Therapeutic Area he had responsibility for the oversight, design, management and execution of Phase 1-2 clinical studies in oncology.
For further information please download PDF below:
